ANSUVIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 15:11:45 UTC 2023` Edited by `admin` on `Sat Dec 16 15:11:45 UTC 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	TG8IQ19NG2
Record Status	`Validated (UNII)`
Record Version

Download

Related Record	Type

Name

Type

Language

ANSUVIMAB

Official Name

English

VRC-EBOMAB092-00-AB

Code

English

ansuvimab [INN]

Common Name

English

Ansuvimab [WHO-DD]

Common Name

English

MAB114

Code

English

ANSUVIMAB [USAN]

Common Name

English

ANTI-EBOLA MONOCLONAL ANTIBODY MAB114

Common Name

English

EVB114

Code

English

MAB-114

Code

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(ZAIRE EBOLAVIRUS ENVELOPE GLYCOPROTEIN GP1 SUBUNIT GLYCAN CAP DOMAIN(SUBUNIT (III))HUMAN MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-449) (HOMO SAPIENS VH (IGHVV3-13*01 (78%) (IGHD)-IGHJ5*01 (93%)) (8.7.13) (1-119)-HOMO SAPI

Common Name

English

EVB-114

Code

English

IMMUNOGLOBULIN G1, ANTI-(ZAIRE EBOLAVIRUS GLYCOPROTEIN GLYCAN CAP AND GP1 DOMAIN) (HUMAN MONOCLONAL MAB114 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MAB114 .KAPPA.-CHAIN, DIMER

Common Name

English

EBOV MAB114

Code

English

Classification Tree Code System Code

FDA ORPHAN DRUG

683019

Created by admin on Sat Dec 16 15:11:45 UTC 2023 , Edited by admin on Sat Dec 16 15:11:45 UTC 2023

FDA ORPHAN DRUG

730820

Created by admin on Sat Dec 16 15:11:45 UTC 2023 , Edited by admin on Sat Dec 16 15:11:45 UTC 2023

Code System Code Type Description

CAS

2375952-29-5

Created by admin on Sat Dec 16 15:11:45 UTC 2023 , Edited by admin on Sat Dec 16 15:11:45 UTC 2023

PRIMARY

INN

11568

Created by admin on Sat Dec 16 15:11:45 UTC 2023 , Edited by admin on Sat Dec 16 15:11:45 UTC 2023

PRIMARY

DAILYMED

TG8IQ19NG2

Created by admin on Sat Dec 16 15:11:45 UTC 2023 , Edited by admin on Sat Dec 16 15:11:45 UTC 2023

PRIMARY

CAS

2266625-91-4

Created by admin on Sat Dec 16 15:11:45 UTC 2023 , Edited by admin on Sat Dec 16 15:11:45 UTC 2023

SUPERSEDED

FDA UNII

TG8IQ19NG2

Created by admin on Sat Dec 16 15:11:45 UTC 2023 , Edited by admin on Sat Dec 16 15:11:45 UTC 2023

PRIMARY

USAN

HI-98

Created by admin on Sat Dec 16 15:11:45 UTC 2023 , Edited by admin on Sat Dec 16 15:11:45 UTC 2023

PRIMARY

RXCUI

2472152

Created by admin on Sat Dec 16 15:11:45 UTC 2023 , Edited by admin on Sat Dec 16 15:11:45 UTC 2023

PRIMARY

NCI_THESAURUS

C175743

Created by admin on Sat Dec 16 15:11:45 UTC 2023 , Edited by admin on Sat Dec 16 15:11:45 UTC 2023

PRIMARY

WIKIPEDIA

Ansuvimab

Created by admin on Sat Dec 16 15:11:45 UTC 2023 , Edited by admin on Sat Dec 16 15:11:45 UTC 2023

PRIMARY

From	To
1_22	1_95
2_22	2_95
2_146	2_202
2_222	4_214
2_263	2_323
1_146	1_202
2_369	2_427
3_23	3_88
3_134	3_194
4_23	4_88
4_134	4_194
1_222	3_214
1_228	2_228
1_231	2_231
1_263	1_323
1_369	1_427

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_299
N	2_299

Related Record Type Details

SUB_CONCEPT->SUBSTANCE

Amount:


					3R8G5WNW24

ZAIRE EBOLAVIRUS

TARGET ORGANISM->INHIBITOR

Related Record Type Details


					TG8IQ19NG2

ANSUVIMAB

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL